BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27646893)

  • 21. SATB2 Expression in Undifferentiated Pleomorphic Sarcomas of Bone.
    Warmke LM; Maloney N; Leung CH; Lin H; Lazar AJ; Wang WL
    Am J Clin Pathol; 2022 Aug; 158(2):235-241. PubMed ID: 35311957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
    Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
    Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of bone GLA protein in primary bone tumors.
    Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
    Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
    Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
    Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitions of osteosarcoma, chondrosarcoma, and fibrosarcoma of bone.
    Sanerkin NG
    Cancer; 1980 Jul; 46(1):178-85. PubMed ID: 6930319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
    Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
    Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumors affecting the temporomandibular joint - a literature review].
    Schlund M; Roland-Billecart T; Aubert S; Nicot R
    Bull Cancer; 2020 Nov; 107(11):1186-1198. PubMed ID: 33059872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
    Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
    Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
    [No Abstract]   [Full Text] [Related]  

  • 29. SATB2 is not a reliable diagnostic marker for distinguishing between oral osteosarcoma and fibro-osseous lesions of the jaws.
    Grad-Akrish S; Rachmiel A; Ben-Izhak O
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):572-581. PubMed ID: 33309262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcomas of bone in childhood: pathologic aspects.
    Kissane JM; Askin FB; Nesbit ME; Vietti TJ; Burgert EO; Cangir A; Gehan EA; Perez CA; Pritchard DJ; Tefft M
    Natl Cancer Inst Monogr; 1981 Apr; (56):29-41. PubMed ID: 6272116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
    Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
    Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases.
    Righi A; Gambarotti M; Manfrini M; Benini S; Gamberi G; Cocchi S; Casadei R; Picci P; Vanel D; Dei Tos AP
    Virchows Arch; 2015 Sep; 467(3):339-44. PubMed ID: 26209924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent In Situ Hybridization for TP53 in the Diagnosis of Pediatric Osteogenic Sarcoma.
    Marrano P; Shago M; Somers GR; Thorner PS
    Am J Surg Pathol; 2018 Jun; 42(6):744-749. PubMed ID: 29543677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the morphologic characteristics of chondrosarcoma and osteogenic sarcomas].
    Shperling ID
    Arkh Patol; 1967; 29(8):68-73. PubMed ID: 5246010
    [No Abstract]   [Full Text] [Related]  

  • 37. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
    Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
    Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
    El-Badawi ZH; Muhammad EM; Noaman HH
    Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epiphyseal osteosarcoma: distinguishing features from clear cell chondrosarcoma, chondroblastoma, and epiphyseal enchondroma.
    Tsuneyoshi M; Dorfman HD
    Hum Pathol; 1987 Jun; 18(6):644-51. PubMed ID: 3474206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
    Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.